NuScale Power (NYSE: SMR) has recently started to move up, along with several other nuclear energy companies. The reason has been increased chatter about establishing nuclear reactors in outer space. The U.S. government says it wants to send those reactors into orbit by 2028 and have them on the moon by 2030. Some believe NuScale is primed to win a contract because of its small modular reactors (S...
NuScale Power (NYSE: SMR) has recently started to move up, along with several other nuclear energy companies. The reason has been increased chatter about establishing nuclear reactors in outer space. The U.S. government says it wants to send those reactors into orbit by 2028 and have them on the moon by 2030. Some believe NuScale is primed to win a contract because of its small modular reactors (SMRs), which could be developed faster and at lower cost than traditional reactors. NuScale may also have an edge in winning potential contracts, as it has the only SMR technology design approved by the U.S. Nuclear Regulatory Commission. This latest push for reactors in space could certainly be bullish for NuScale's long-term prospects, but shares have dropped by 70% over the past six months for a reason. Continue reading
X Square Robot on Tuesday unveiled Wall-B, a new embodied AI foundation model designed for deployment in real-world homes, marking what the company described as a major step toward bringing general-purpose robots into daily family life.
X Square Robot on Tuesday unveiled Wall-B, a new embodied AI foundation model designed for deployment in real-world homes, marking what the company described as a major step toward bringing general-purpose robots into daily family life.
In this article ROP-CH NES.N-CH SAP-DE SAP SNY DG-FR LSEG-GB ORA-FR NOK NOA3-DE HEIA-NL SDV1-FF SDV1-FF STM DSY-FR RNO-FR Follow your favorite stocks CREATE FREE ACCOUNT A stock trader looks at his monitors in the trading room of the Frankfurt Stock Exchange. Worries about a new coronavirus mutation in southern Africa have dealt a major blow to the German stock market. Arne Dedert | Picture Allian...
In this article ROP-CH NES.N-CH SAP-DE SAP SNY DG-FR LSEG-GB ORA-FR NOK NOA3-DE HEIA-NL SDV1-FF SDV1-FF STM DSY-FR RNO-FR Follow your favorite stocks CREATE FREE ACCOUNT A stock trader looks at his monitors in the trading room of the Frankfurt Stock Exchange. Worries about a new coronavirus mutation in southern Africa have dealt a major blow to the German stock market. Arne Dedert | Picture Alliance | Getty Images LONDON — European stocks are expected to open in negative territory on Thursday as regional market sentiment remains downbeat and oil prices tick higher. The U.K.'s FTSE 100 index is seen opening 0.7% lower, with Germany's DAX down 1.3%, France's CAC 40 down 0.77% and Italy's FTSE MIB 0.9% lower, according to data from IG. International benchmark Brent crude rose almost 1.3% to $103.19 per barrel by 1:19 a.m. ET on Thursday, following media reports that the U.S. has intercepted at least three Iranian oil tankers in Asian waters, heightening uncertainty that the Middle East conflict may drag on. European bourses missed out on gains enjoyed by U.S. peers on Wednesday, closing lower as investors weighed an extension of the Iran war ceasefire with the continued blockage of the Strait of Hormuz. Sentiment was also kept in check after Germany halved its economic growth forecasts for 2026, with officials saying they now expect Europe's largest economy to grow just 0.5% this year. For 2027, the GDP forecast was trimmed from 1.3% to 0.9%. Germany's Economics Ministry cited the Iran war and closure of the Strait of Hormuz as reasons for the downgrades, and said the country had seen costs for households and businesses rise. Officials projected that inflation would rise to 2.7% this year and 2.8% next year. Japan and South Korea stocks hit record highs overnight, before Asia-Pacific markets retreated into negative territory, following the reports of Iran tanker interceptions. S&P 500 futures were little changed Wednesday night. It's another busy day for earnings in Eu...
Ipsen S.A. press release ( IPSEY ): Q1 Revenue of €1.07B (+16.5% Y/Y). Full-year guidance 2026 Ipsen is confirming its financial guidance for full-year 2026: • Total sales growth greater than 13.0%, at constant currency, assuming accelerated sales growth of the portfolio excluding Somatuline and the growth of Somatuline sales due to generic lanreotide challenges. Based on the average level of exch...
Ipsen S.A. press release ( IPSEY ): Q1 Revenue of €1.07B (+16.5% Y/Y). Full-year guidance 2026 Ipsen is confirming its financial guidance for full-year 2026: • Total sales growth greater than 13.0%, at constant currency, assuming accelerated sales growth of the portfolio excluding Somatuline and the growth of Somatuline sales due to generic lanreotide challenges. Based on the average level of exchange rates in March 2026, an adverse effect on total sales of around 1% of currencies is expected. Core operating margin greater than 35.0% of total sales. More on Ipsen S.A. Ipsen S.A. (IPSEY) Q4 2025 Earnings Call Transcript Ipsen S.A. 2025 Q4 - Results - Earnings Call Presentation Genfit adds $20M as Ipsen records strong sales for liver drug Ipsen S.A. Non-GAAP EPS of €12.09, revenue of €3.68B; sets full-year 2026 guidance and mid-term outlook Historical earnings data for Ipsen S.A.
A Hong Kong insurance brokerage CEO’s suspected embezzlement of about HK$43 million ($5.5 million) has drawn fresh attention to concerns over how IPO shares are allocated. Police detained the 53-year-old CEO surnamed He in mid-April after receiving a report from an employee at another company. The CEO worked for Sunbright Wealth Management Ltd., a licensed insurance brokerage. The alleged transfer...
A Hong Kong insurance brokerage CEO’s suspected embezzlement of about HK$43 million ($5.5 million) has drawn fresh attention to concerns over how IPO shares are allocated. Police detained the 53-year-old CEO surnamed He in mid-April after receiving a report from an employee at another company. The CEO worked for Sunbright Wealth Management Ltd., a licensed insurance brokerage. The alleged transfers were discovered after the company faced a cash shortfall and sought support from shareholders, people familiar with the matter told Caixin.
The country-hopping contestants turn their sights to Tbilisi in Georgia. Plus, a big Robert Lindsay reveal in Big Mood. Here’s what to watch this evening 8pm, BBC One It’s hotting up in Turkey as the fourth leg begins, and the teams set off for their next checkpoint: Georgia’s capital, Tbilisi. Three teams turn their feet east but one decides to go rogue, heading north to the Black Sea coast via a...
The country-hopping contestants turn their sights to Tbilisi in Georgia. Plus, a big Robert Lindsay reveal in Big Mood. Here’s what to watch this evening 8pm, BBC One It’s hotting up in Turkey as the fourth leg begins, and the teams set off for their next checkpoint: Georgia’s capital, Tbilisi. Three teams turn their feet east but one decides to go rogue, heading north to the Black Sea coast via a 14-hour slog of a bus journey. Will it pay off? Lucinda Everett Continue reading...
panida wijitpanya/iStock via Getty Images By Padhraic Garvey, CFA , Regional Head of Research, Americas There are more pressures, but they are only mild The market discount through to the end of March centred on the freezing of the Strait of Hormuz as critical. Fast-forward to this week, and equity markets impliedly think it's not that critical after all. The oil price, of course, has come under r...
panida wijitpanya/iStock via Getty Images By Padhraic Garvey, CFA , Regional Head of Research, Americas There are more pressures, but they are only mild The market discount through to the end of March centred on the freezing of the Strait of Hormuz as critical. Fast-forward to this week, and equity markets impliedly think it's not that critical after all. The oil price, of course, has come under renewed upward pressure, but only to the extent that it's the correct reaction to the ongoing closure of the Strait and the threat from Iran not to negotiate until the US blockade is removed. And bond yields, too, have shown a tendency to edge higher, in tandem with a re-ratchet higher in front-end inflation expectations (albeit mild). We continue to find ourselves in an uncomfortable holding ground as we await the US and Iran to come to some semblance of agreement. And an agreement of sorts remains the most likely outcome. If not, and things turn materially worse (not our base view), everything sells off (risk assets and bonds), apart from energy prices and volatility. Our models continue to point to a dominant rate cut outcome in the quarters ahead, and that’s not discounting front-end pricing. A worsening in the war narrative presents the biggest risk to this trade, as the higher inflation outcome would make rate cuts more difficult to deliver, at least in the immediate few months. We still think the war is in a wind-down phase, albeit uncomfortable. But even if the Iran war ended today and the Strait reopened instantaneously (still a stretch), we are left with significant price pressure that has yet to filter through. And it’s not just the wider energy price complex; it’s also the likes of fertiliser, which risk adding to food prices in subsequent months down the line. Big picture, the US 2/10yr curve remains remarkably flat. Especially considering we are (eventually) nearing the tail end of a rate-cutting process. That aside, we identify room for short-tenor rates to fa...
Teck Resources press release ( TECK ): Q1 Non-GAAP EPS of C$1.75 beats by C$0.64 . Revenue of C$3.94B (+72.1% Y/Y) beats by C$720M . Adjusted EBITDA 1 of C$2.1 billion in Q1 2026 was C$1.2 billion or 125% higher than the same period last year. Cash flow from operations of C$1.0 billion increased our net cash 1 position by C$338 million at March 31, 2026. QB copper sales volumes of 70,300 tonnes in...
Teck Resources press release ( TECK ): Q1 Non-GAAP EPS of C$1.75 beats by C$0.64 . Revenue of C$3.94B (+72.1% Y/Y) beats by C$720M . Adjusted EBITDA 1 of C$2.1 billion in Q1 2026 was C$1.2 billion or 125% higher than the same period last year. Cash flow from operations of C$1.0 billion increased our net cash 1 position by C$338 million at March 31, 2026. QB copper sales volumes of 70,300 tonnes in Q1 2026 were a quarterly record and materially exceeded production volumes of 55,500 tonnes as inventory was drawn down. Guidance There are no changes to our previously disclosed guidance, which is outlined in summary below and our usual guidance tables, including 2027–2028 production guidance, can be found on pages 26–29 of Teck’s first quarter results for 2026 at the link below. 2026 Guidance – Summary Current Production Guidance Copper (000’s tonnes) 455 – 530 Zinc (000’s tonnes) 410 – 460 Refined zinc (000’s tonnes) 190 – 230 Sales Guidance – Q2 2026 Red Dog zinc in concentrate sales (000’s tonnes) 30 – 40 Unit Cost Guidance Copper net cash unit costs (US$/lb.) 1 1.85 – 2.20 Zinc net cash unit costs (US$/lb.) 1 0.65 – 0.75 Click to enlarge More on Teck Resources Limited Teck Resources: A Copper Giant In Transition, Still Priced As A Legacy Miner Teck Resources Limited (TECK.B:CA) Presents at 35th BMO Global Metals, Mining & Critical Minerals Conference - Slideshow Teck Resources Limited (TECK.B:CA) Q4 2025 Earnings Call Transcript Teck Resources Q1 2026 Earnings Preview Teck Resources to sell zinc, silver, and germanium to Korea Zinc at higher prices in 2026
Hyundai Motor Co. first-quarter earnings missed estimates, as South Korea’s largest automaker grappled with US tariffs and cooling demand in key markets. Operating profit fell almost 31% to 2.5 trillion won ($1.7 billion) in the three months ended March 31 from a year earlier, the Seoul-based company said Thursday. That fell short of the 2.8 trillion won analyst consensus , according to data compi...
Hyundai Motor Co. first-quarter earnings missed estimates, as South Korea’s largest automaker grappled with US tariffs and cooling demand in key markets. Operating profit fell almost 31% to 2.5 trillion won ($1.7 billion) in the three months ended March 31 from a year earlier, the Seoul-based company said Thursday. That fell short of the 2.8 trillion won analyst consensus , according to data compiled by Bloomberg. Revenue rose 3.4% to 45.9 trillion won, a record for the first quarter. Sales fell in its home market, China and Europe. The results highlight how the stalling transition to electric vehicles and intensifying competition with Chinese rivals are casting a shadow over the sales outlook for South Korean carmakers. Meanwhile, the Iran war is disrupting supply chains and driving up production costs, threatening to damp global consumer sentiment even further. Hyundai and its affiliate Kia Corp. continue to face the fallout from US tariffs, which cost the two companies more than $5 billion combined last year and contributed to Hyundai’s lowest quarterly profit in more than three years during the final quarter. While auto levies have since been reduced to 15% from 25% under a trade deal between the two countries, the ongoing pressure remains a drag on margins. Hyundai shares fell as much as 3% in Seoul trading before paring earlier losses. Despite the headwinds, the stock has rallied nearly 80% this year, buoyed largely by investor optimism surrounding the company’s push into robotics following the unveiling of its latest Atlas humanoid model.
Roche Holding AG reported declining sales for the first quarter, hurt by competition for its older medicines and the Swiss franc’s appreciation against the dollar. Revenue fell 5% to 14.7 billion Swiss francs ($18.7 billion), Roche said Thursday , compared with an average analyst prediction of 15.1 billion francs. It grew 6% at constant currencies. Roche is using a combination of deal-making and a...
Roche Holding AG reported declining sales for the first quarter, hurt by competition for its older medicines and the Swiss franc’s appreciation against the dollar. Revenue fell 5% to 14.7 billion Swiss francs ($18.7 billion), Roche said Thursday , compared with an average analyst prediction of 15.1 billion francs. It grew 6% at constant currencies. Roche is using a combination of deal-making and aggressive moves on its own portfolio to replace some 5.8 billion francs in revenue analysts expect will be lost to cheaper copycat drugs by 2029, with a focus on obesity and related illnesses. The Swiss drugmaker is also tightening costs. Read More: Roche Restricts Consulting Work With Big Four Firms to Cut Costs Key to Roche’s competitiveness are late-stage trial results, which have been mixed recently. The company this week said an experimental multiple-sclerosis pill roughly halved the number of disease relapses in two key studies, but more patients died while on the medicine, which didn’t alleviate safety concerns. Roche shares have declined almost 5% this year. That compares with a 5.5% gain for local rival Novartis AG , which is also on a deal streak as its aging best-sellers face generic competition. Roche is largely shielded from the new US drug tariffs, with an agreement for a three-year exemption and billions being spent to ramp up its US presence to mitigate future trade risks. The drugmaker reiterated its forecast for the year, with earnings per share excluding some items growing in the high single-digit range at constant currencies this year.
BE Semiconductor Industries (BESI) on Thursday reported quarterly orders above last year's level, reflecting growth across all its markets and particularly strong demand for hybrid bonding. Investors are banking on growing orders for Besi's hybrid bonding solutions, a chip technology allowing two chips to be bonded directly on top of each other, citing its first-mover advantage amid a surge i...
BE Semiconductor Industries (BESI) on Thursday reported quarterly orders above last year's level, reflecting growth across all its markets and particularly strong demand for hybrid bonding. Investors are banking on growing orders for Besi's hybrid bonding solutions, a chip technology allowing two chips to be bonded directly on top of each other, citing its first-mover advantage amid a surge in demand for AI-enabling technology. Besi said its order bookings, an important indicator of future growth, jumped 104.5% to 269.7 million euros ($315.5 million) in the first quarter, compared with 131.9 million euros last year.